NPI: 1285641514 · NEW HYDE PARK, NY 11040 · General Acute Care Hospital · NPI assigned 08/01/2006
Authorized official CUSACK, MICHELE controls 20+ related entities in our dataset. Read more
| Authorized Official | CUSACK, MICHELE (SENIOR VICE PRESIDENT & CFO) |
| NPI Enumeration Date | 08/01/2006 |
Other providers sharing the same authorized official: CUSACK, MICHELE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 58,573 | $3.41M |
| 2019 | 261,587 | $21.52M |
| 2020 | 585,684 | $52.28M |
| 2021 | 749,569 | $73.61M |
| 2022 | 801,785 | $78.42M |
| 2023 | 837,545 | $79.81M |
| 2024 | 711,921 | $61.86M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 2,183 | 1,725 | $30.15M |
| J7170 | Injection, emicizumab-kxwh, 0.5 mg | 1,072 | 1,043 | $26.52M |
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 114,880 | 110,331 | $24.55M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 117,667 | 111,626 | $23.28M |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 2,337 | 2,155 | $18.13M |
| 99214 | Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 125,219 | 109,276 | $17.44M |
| 90834 | Psychotherapy, 45 minutes with patient | 62,861 | 29,379 | $10.96M |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 73,912 | 60,681 | $9.90M |
| 90832 | Psychotherapy, 30 minutes with patient | 61,615 | 34,224 | $8.62M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 42,590 | 41,057 | $8.33M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 35,706 | 34,956 | $7.39M |
| H0005 | Alcohol and/or drug services; group counseling by a clinician | 51,592 | 11,494 | $6.29M |
| J9299 | Injection, nivolumab, 1 mg | 449 | 331 | $4.79M |
| 36430 | 6,621 | 4,368 | $4.58M | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 24,994 | 15,893 | $4.42M |
| G0378 | Hospital observation service, per hour | 6,822 | 4,921 | $3.97M |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 15,376 | 15,016 | $3.78M |
| J2505 | Injection, pegfilgrastim, 6 mg | 754 | 554 | $3.27M |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 29,423 | 7,987 | $3.24M |
| 70450 | Computed tomography, head or brain; without contrast material | 14,024 | 13,695 | $3.12M |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | 1,682 | 1,659 | $3.12M |
| H0020 | Alcohol and/or drug services; methadone administration and/or service (provision of the drug by a licensed program) | 75,116 | 12,839 | $3.09M |
| P9040 | Red blood cells, leukocytes reduced, irradiated, each unit | 5,662 | 4,327 | $3.05M |
| J0897 | Injection, denosumab, 1 mg | 1,057 | 1,026 | $2.89M |
| 99215 | Prolong outpt/office vis | 16,613 | 15,910 | $2.86M |
| Q5118 | Injection, bevacizumab-bvzr, biosimilar, (zirabev), 10 mg | 896 | 562 | $2.83M |
| 80053 | Comprehensive metabolic panel | 160,202 | 140,980 | $2.82M |
| Q5104 | Injection, infliximab-abda, biosimilar, (renflexis), 10 mg | 639 | 596 | $2.78M |
| 36416 | 59,377 | 35,335 | $2.78M | |
| 90853 | Group psychotherapy (other than of a multiple-family group) | 41,407 | 13,226 | $2.78M |
| C1889 | Implantable/insertable device, not otherwise classified | 6,738 | 5,775 | $2.75M |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 4,213 | 4,193 | $2.67M |
| 96415 | 7,431 | 4,719 | $2.62M | |
| J9355 | Injection, trastuzumab, excludes biosimilar, 10 mg | 469 | 321 | $2.59M |
| H2019 | Therapeutic behavioral services, per 15 minutes | 4,684 | 4,554 | $2.50M |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1,119 | 808 | $2.40M |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 15,645 | 10,144 | $2.35M |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 18,662 | 14,379 | $2.33M |
| G2067 | Medication assisted treatment, methadone; weekly bundle including dispensing and/or administration, substance use counseling, individual and group therapy, and toxicology testing, if performed (provision of the services by a medicare-enrolled opioid treatment program) | 11,039 | 5,443 | $2.28M |
| 36415 | Collection of venous blood by venipuncture | 189,571 | 101,956 | $2.18M |
| 96361 | Intravenous infusion, hydration; each additional hour | 10,459 | 8,785 | $2.09M |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | 5,817 | 5,681 | $2.04M |
| J9144 | Injection, daratumumab, 10 mg and hyaluronidase-fihj | 215 | 115 | $1.93M |
| 59025 | Fetal non-stress test | 13,301 | 11,072 | $1.91M |
| 77386 | 6,816 | 646 | $1.84M | |
| 70551 | Magnetic resonance imaging, brain; without contrast material | 4,887 | 4,771 | $1.68M |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 19,699 | 19,149 | $1.67M |
| 90870 | 3,485 | 1,526 | $1.60M | |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | 3,128 | 3,055 | $1.55M |
| 90792 | Psychiatric diagnostic evaluation with medical services | 6,548 | 5,889 | $1.50M |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 155 | 133 | $1.49M |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11,247 | 11,123 | $1.31M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11,044 | 11,011 | $1.31M |
| H0004 | Behavioral health counseling and therapy, per 15 minutes | 15,608 | 9,154 | $1.18M |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | 1,696 | 1,684 | $1.18M |
| Q5117 | Injection, trastuzumab-anns, biosimilar, (kanjinti), 10 mg | 392 | 262 | $1.15M |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 11,460 | 9,759 | $1.12M |
| 86900 | 40,077 | 34,188 | $1.11M | |
| 76770 | 3,533 | 3,463 | $1.05M | |
| 77336 | 3,473 | 1,767 | $992K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 4,129 | 4,042 | $979K |
| 77412 | 3,180 | 441 | $958K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | 15,696 | 15,227 | $916K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 5,052 | 4,952 | $857K |
| 86901 | 39,843 | 33,996 | $857K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | 9,925 | 2,881 | $801K |
| 86850 | 39,500 | 33,844 | $797K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 713 | 688 | $794K |
| J9306 | Injection, pertuzumab, 1 mg | 80 | 61 | $772K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | 12,655 | 12,159 | $740K |
| 99203 | Office or other outpatient visit for the evaluation and management of a new patient, low complexity | 5,720 | 5,649 | $740K |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 1,076 | 719 | $736K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 4,218 | 3,058 | $726K |
| 96416 | 1,753 | 1,025 | $718K | |
| 12011 | 1,939 | 1,931 | $710K | |
| 12001 | 1,824 | 1,818 | $703K | |
| 36000 | 34,908 | 32,423 | $674K | |
| Q5108 | Injection, pegfilgrastim-jmdb (fulphila), biosimilar, 0.5 mg | 208 | 159 | $666K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 5,084 | 5,069 | $641K |
| 96375 | Therapeutic injection; each additional sequential IV push | 40,875 | 33,296 | $627K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | 1,581 | 1,526 | $623K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | 2,763 | 2,713 | $610K |
| 71275 | Computed tomographic angiography, chest, with contrast material | 2,812 | 2,740 | $602K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 59,594 | 54,659 | $586K |
| 99204 | Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 3,789 | 3,746 | $579K |
| P9037 | Platelets, pheresis, leukocytes reduced, irradiated, each unit | 653 | 296 | $573K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | 11,918 | 3,513 | $571K |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 6,953 | 1,657 | $541K |
| J1756 | Injection, iron sucrose, 1 mg | 7,812 | 3,736 | $523K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | 4,889 | 3,945 | $522K |
| 76830 | Ultrasound, transvaginal | 7,206 | 6,859 | $511K |
| 93970 | 1,353 | 1,330 | $502K | |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 7,123 | 5,274 | $501K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 376 | 375 | $492K |
| H0035 | Mental health partial hospitalization, treatment, less than 24 hours | 1,904 | 260 | $490K |
| H2011 | Crisis intervention service, per 15 minutes | 1,961 | 1,672 | $490K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 14,442 | 12,963 | $484K |
| 58558 | 389 | 389 | $470K | |
| 90791 | Psychiatric diagnostic evaluation | 2,139 | 2,090 | $469K |
| 14040 | 323 | 322 | $467K | |
| 74183 | 946 | 927 | $450K | |
| 96450 | 1,021 | 876 | $442K | |
| 90836 | 3,619 | 1,834 | $426K | |
| 93975 | 942 | 931 | $415K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | 1,245 | 1,224 | $412K |
| 54161 | 542 | 538 | $409K | |
| 85027 | 85,847 | 65,919 | $384K | |
| J9217 | Leuprolide acetate (for depot suspension), 7.5 mg | 1,090 | 1,049 | $382K |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 205 | 183 | $382K |
| G0498 | Chemotherapy administration, intravenous infusion technique; initiation of infusion in the office/clinic setting using office/clinic pump/supplies, with continuation of the infusion in the community setting (e.g., home, domiciliary, rest home or assisted living) using a portable pump provided by the office/clinic, includes follow up office/clinic visit at the conclusion of the infusion | 592 | 356 | $381K |
| C1769 | Guide wire | 2,228 | 2,155 | $379K |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | 4,223 | 3,844 | $378K |
| 77334 | 1,366 | 1,041 | $376K | |
| 92551 | 7,692 | 7,548 | $376K | |
| 96367 | 4,872 | 3,178 | $374K | |
| 96409 | 4,715 | 2,576 | $374K | |
| H0002 | Behavioral health screening to determine eligibility for admission to treatment program | 1,395 | 1,370 | $369K |
| 70498 | 1,847 | 1,791 | $366K | |
| 90837 | Psychotherapy, 53 minutes with patient | 2,200 | 1,169 | $364K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 2,952 | 2,915 | $359K |
| H2010 | Comprehensive medication services, per 15 minutes | 4,054 | 3,340 | $354K |
| 10060 | 1,269 | 1,247 | $351K | |
| A9585 | Injection, gadobutrol, 0.1 ml | 4,990 | 4,947 | $339K |
| 85045 | 23,718 | 18,311 | $336K | |
| 76818 | 4,125 | 2,832 | $335K | |
| 72197 | 705 | 693 | $334K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 11,211 | 11,133 | $320K |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | 11,017 | 10,778 | $316K |
| 77300 | 1,161 | 1,089 | $310K | |
| 90847 | Family psychotherapy with the patient present, 50 minutes | 1,233 | 913 | $308K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 4,334 | 1,209 | $302K |
| 80048 | Basic metabolic panel (calcium, ionized) | 19,245 | 18,620 | $299K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 25,344 | 21,946 | $299K |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 3,613 | 3,383 | $296K |
| 81220 | CFTR (cystic fibrosis transmembrane conductance regulator) gene analysis; common variants | 1,701 | 1,667 | $295K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | 2,307 | 2,283 | $294K |
| 92526 | 2,648 | 1,232 | $291K | |
| J1453 | Injection, fosaprepitant, 1 mg | 3,729 | 2,351 | $290K |
| J9305 | Injection, pemetrexed, not otherwise specified, 10 mg | 124 | 74 | $290K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13,636 | 12,701 | $289K |
| 99157 | 1,783 | 1,760 | $284K | |
| Q5119 | Injection, rituximab-pvvr, biosimilar, (ruxience), 10 mg | 59 | 41 | $271K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 9,286 | 8,635 | $271K |
| J9070 | Cyclophosphamide, 100 mg | 800 | 524 | $270K |
| 96523 | 13,438 | 6,453 | $268K | |
| 90839 | 1,545 | 1,452 | $267K | |
| 47562 | 137 | 137 | $266K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | 434 | 433 | $265K |
| 71046 | Radiologic examination, chest; 2 views | 31,761 | 30,568 | $264K |
| J2469 | Injection, palonosetron hcl, 25 mcg | 8,977 | 5,398 | $260K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | 614 | 569 | $258K |
| 96417 | 5,159 | 3,314 | $257K | |
| 97161 | 2,310 | 2,305 | $253K | |
| J9041 | Injection, bortezomib, 0.1 mg | 374 | 126 | $250K |
| 90846 | Family psychotherapy without the patient present, 50 minutes | 1,874 | 1,373 | $247K |
| 77290 | 616 | 582 | $242K | |
| 72141 | 783 | 766 | $240K | |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1,156 | 1,135 | $240K |
| J3490 | Unclassified drugs | 55,717 | 40,000 | $239K |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 16,311 | 15,974 | $238K |
| 90670 | 7,704 | 7,696 | $223K | |
| 51600 | 409 | 402 | $220K | |
| 70491 | 930 | 911 | $218K | |
| 47563 | 95 | 95 | $202K | |
| 29125 | 944 | 927 | $202K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 974 | 847 | $200K |
| J0640 | Injection, leucovorin calcium, per 50 mg | 2,492 | 1,418 | $198K |
| 76000 | 2,593 | 2,546 | $196K | |
| 36591 | 10,201 | 6,019 | $196K | |
| 76536 | 1,979 | 1,921 | $194K | |
| 12002 | 502 | 499 | $193K | |
| 96411 | 3,508 | 2,307 | $189K | |
| 86480 | 3,174 | 3,125 | $186K | |
| 0225U | 25,155 | 24,318 | $185K | |
| 70496 | 1,901 | 1,840 | $178K | |
| 99381 | 1,669 | 1,663 | $178K | |
| 86902 | 2,820 | 2,198 | $176K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 12,507 | 12,329 | $175K |
| J7030 | Infusion, normal saline solution , 1000 cc | 66,519 | 56,366 | $174K |
| 71250 | 1,260 | 1,232 | $172K | |
| 82803 | 13,370 | 12,485 | $172K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 68,462 | 60,378 | $168K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | 1,169 | 1,145 | $168K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 7,664 | 7,430 | $167K |
| 10E0XZZ | 280 | 30 | $165K | |
| 93971 | 2,389 | 2,341 | $165K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 8,439 | 8,164 | $164K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 55,068 | 51,404 | $164K |
| 93017 | 2,314 | 2,277 | $160K | |
| Q5121 | Injection, infliximab-axxq, biosimilar, (avsola), 10 mg | 285 | 233 | $158K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1,082 | 1,081 | $153K |
| 97116 | 3,125 | 996 | $152K | |
| 90715 | 6,626 | 6,304 | $152K | |
| 99173 | 5,877 | 5,864 | $146K | |
| 83880 | 7,305 | 7,192 | $145K | |
| 99385 | 1,101 | 1,090 | $144K | |
| 51701 | 607 | 601 | $142K | |
| J0885 | Injection, epoetin alfa, (for non-esrd use), 1000 units | 345 | 208 | $141K |
| 70486 | 1,718 | 1,674 | $141K | |
| 76870 | 1,897 | 1,814 | $141K | |
| 44970 | 69 | 69 | $135K | |
| 25605 | 287 | 285 | $134K | |
| A9502 | Technetium tc-99m tetrofosmin, diagnostic, per study dose | 1,110 | 1,100 | $133K |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 1,043 | 1,032 | $132K |
| J9264 | Injection, paclitaxel protein-bound particles, 1 mg | 59 | 24 | $130K |
| J7050 | Infusion, normal saline solution, 250 cc | 36,143 | 19,099 | $130K |
| 88307 | 2,012 | 1,975 | $129K | |
| 76801 | 1,753 | 1,589 | $128K | |
| 92567 | 4,665 | 4,619 | $121K | |
| 74230 | 1,271 | 1,250 | $121K | |
| J9263 | Injection, oxaliplatin, 0.5 mg | 855 | 514 | $121K |
| J2785 | Injection, regadenoson, 0.1 mg | 536 | 501 | $118K |
| 90461 | 5,982 | 5,965 | $117K | |
| 92579 | 1,840 | 1,832 | $117K | |
| 82728 | 12,424 | 11,132 | $114K | |
| 31575 | 831 | 820 | $114K | |
| 86923 | 4,255 | 3,666 | $113K | |
| 96376 | 6,365 | 5,302 | $112K | |
| 90686 | 11,776 | 11,612 | $111K | |
| 92652 | 868 | 859 | $110K | |
| C9399 | Unclassified drugs or biologicals | 1,814 | 1,802 | $110K |
| 99155 | 1,184 | 1,151 | $110K | |
| D7140 | Extraction, erupted tooth or exposed root | 374 | 367 | $109K |
| 96402 | 1,853 | 1,746 | $109K | |
| 96401 | 1,508 | 598 | $108K | |
| D1110 | Prophylaxis - adult | 1,354 | 561 | $107K |
| 78815 | Positron emission tomography (PET) for limited area imaging | 71 | 68 | $102K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 12,741 | 12,378 | $101K |
| 99156 | 1,876 | 1,764 | $100K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 11,538 | 10,542 | $99K |
| 31231 | 710 | 705 | $99K | |
| 95810 | Polysomnography; sleep staging with 4 or more additional parameters | 133 | 115 | $95K |
| 99051 | 4,561 | 2,512 | $94K | |
| 88185 | 272 | 226 | $92K | |
| H0038 | Self-help/peer services, per 15 minutes | 1,228 | 548 | $88K |
| 77295 | 344 | 311 | $88K | |
| C1781 | Mesh (implantable) | 193 | 189 | $87K |
| 72125 | Computed tomography, cervical spine; without contrast material | 2,478 | 2,416 | $86K |
| J9045 | Injection, carboplatin, 50 mg | 2,294 | 1,476 | $86K |
| 92611 | 638 | 633 | $85K | |
| H2018 | Psychosocial rehabilitation services, per diem | 220 | 213 | $84K |
| J9190 | Injection, fluorouracil, 500 mg | 2,965 | 1,427 | $83K |
| 19301 | 37 | 37 | $81K | |
| 24640 | 215 | 212 | $81K | |
| J9267 | Injection, paclitaxel, 1 mg | 2,541 | 1,315 | $81K |
| 90716 | 4,078 | 4,071 | $81K | |
| 81025 | 23,293 | 21,928 | $77K | |
| J9206 | Injection, irinotecan, 20 mg | 1,370 | 740 | $77K |
| 90698 | 7,866 | 7,860 | $73K | |
| 90680 | 6,160 | 6,157 | $73K | |
| 80061 | Lipid panel | 6,878 | 6,629 | $72K |
| 76819 | Fetal biophysical profile; without non-stress testing | 1,000 | 924 | $71K |
| 77301 | 94 | 90 | $71K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | 108 | 108 | $71K |
| 95710 | 165 | 165 | $70K | |
| 90378 | 126 | 124 | $69K | |
| 81507 | 308 | 308 | $69K | |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 547 | 529 | $69K |
| 74455 | 405 | 390 | $69K | |
| 87800 | 3,216 | 3,149 | $68K | |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 895 | 868 | $68K |
| 29515 | 335 | 334 | $67K | |
| G0121 | Colorectal cancer screening; colonoscopy on individual not meeting criteria for high risk | 88 | 88 | $66K |
| 99205 | Prolong outpt/office vis | 354 | 353 | $65K |
| 97162 | 671 | 663 | $63K | |
| 49505 | 29 | 28 | $62K | |
| 83735 | 28,513 | 23,297 | $62K | |
| 77280 | 150 | 137 | $62K | |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | 2,230 | 2,215 | $61K |
| 86922 | 1,576 | 1,180 | $61K | |
| 76885 | 645 | 634 | $60K | |
| 96160 | 3,025 | 3,010 | $60K | |
| 76882 | 1,125 | 1,079 | $59K | |
| 90849 | 733 | 332 | $59K | |
| 95708 | 283 | 279 | $58K | |
| 92014 | Ophthalmological services: medical examination and evaluation, comprehensive, established patient | 481 | 423 | $58K |
| 84702 | 29,095 | 26,751 | $58K | |
| 92557 | 1,164 | 1,150 | $57K | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 3,036 | 3,017 | $57K |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | 883 | 705 | $55K |
| 72131 | 464 | 455 | $55K | |
| 71045 | Radiologic examination, chest; single view | 15,468 | 14,869 | $54K |
| V5020 | Conformity evaluation | 902 | 794 | $54K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | 6,460 | 6,373 | $53K |
| 92587 | 1,182 | 1,177 | $52K | |
| 82607 | 3,966 | 3,847 | $51K | |
| 70487 | 219 | 210 | $51K | |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 258 | 127 | $50K |
| 88304 | 2,086 | 2,068 | $50K | |
| 92012 | Ophthalmological services: medical examination and evaluation, intermediate, established patient | 376 | 293 | $49K |
| 92610 | 809 | 784 | $48K | |
| 92582 | 435 | 434 | $48K | |
| 75561 | 68 | 68 | $47K | |
| 90651 | 1,340 | 1,325 | $46K | |
| 90899 | 688 | 616 | $45K | |
| 29888 | 14 | 14 | $45K | |
| 97535 | Self-care/home management training, each 15 minutes | 674 | 346 | $44K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 358 | 345 | $43K |
| 76775 | 632 | 625 | $43K | |
| 73700 | 216 | 215 | $43K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 14,527 | 14,242 | $43K |
| 96522 | 812 | 689 | $43K | |
| 84443 | Thyroid stimulating hormone (TSH) | 16,096 | 15,525 | $43K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 30,021 | 28,017 | $42K |
| 87653 | 1,643 | 1,639 | $42K | |
| 86769 | 2,980 | 2,911 | $42K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 7,556 | 7,112 | $42K |
| 81003 | 44,133 | 35,481 | $41K | |
| 90633 | 4,362 | 4,356 | $41K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 8,468 | 8,130 | $41K |
| 83020 | 4,725 | 3,937 | $41K | |
| 58300 | 326 | 321 | $41K | |
| 70543 | 107 | 104 | $41K | |
| S5102 | Day care services, adult; per diem | 253 | 24 | $39K |
| 74174 | 158 | 155 | $39K | |
| 84100 | 17,445 | 13,370 | $39K | |
| 86780 | 10,167 | 9,996 | $39K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 11,089 | 10,008 | $38K |
| 78451 | 122 | 106 | $38K | |
| 74018 | 2,934 | 2,829 | $37K | |
| 81001 | 52,940 | 50,261 | $37K | |
| G0108 | Diabetes outpatient self-management training services, individual, per 30 minutes | 1,367 | 829 | $37K |
| 86703 | 3,409 | 3,376 | $37K | |
| 87507 | 712 | 708 | $35K | |
| 83550 | 8,851 | 8,243 | $35K | |
| 69210 | 504 | 494 | $34K | |
| 90707 | 3,566 | 3,560 | $34K | |
| 83655 | 2,531 | 2,508 | $34K | |
| 49650 | 13 | 13 | $34K | |
| 51702 | 139 | 136 | $34K | |
| 81420 | Fetal chromosomal aneuploidy genomic sequence analysis panel | 101 | 100 | $34K |
| 85245 | 881 | 828 | $33K | |
| 72156 | 87 | 86 | $33K | |
| P9100 | Pathogen(s) test for platelets | 597 | 266 | $33K |
| J7060 | 5% dextrose/water (500 ml = 1 unit) | 7,711 | 4,345 | $33K |
| 95700 | 301 | 297 | $32K | |
| 29065 | 106 | 103 | $31K | |
| 77338 | 66 | 65 | $31K | |
| 82248 | 8,046 | 5,700 | $31K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 40,803 | 39,088 | $30K |
| 85610 | 24,523 | 22,952 | $30K | |
| 83615 | 8,949 | 7,085 | $30K | |
| 86803 | 5,731 | 5,672 | $29K | |
| 76857 | 655 | 638 | $29K | |
| 88312 | 2,105 | 2,080 | $29K | |
| 85380 | 1,823 | 1,769 | $29K | |
| 99195 | 418 | 366 | $28K | |
| 99402 | 400 | 394 | $28K | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | 13,623 | 13,235 | $28K |
| J9370 | Vincristine sulfate, 1 mg | 2,837 | 2,021 | $28K |
| 87806 | 1,766 | 1,743 | $28K | |
| 49591 | 15 | 15 | $27K | |
| 88342 | 1,024 | 991 | $27K | |
| 72146 | 132 | 127 | $27K | |
| 83540 | 7,225 | 6,676 | $26K | |
| D0120 | Periodic oral evaluation - established patient | 436 | 234 | $26K |
| 82784 | 2,031 | 1,875 | $26K | |
| 83021 | 974 | 786 | $26K | |
| M0222 | Intravenous injection, bebtelovimab, includes injection and post administration monitoring | 124 | 121 | $26K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | 322 | 295 | $26K |
| J2704 | Injection, propofol, 10 mg | 10,009 | 8,989 | $26K |
| 88341 | 1,020 | 976 | $26K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 27,899 | 25,561 | $25K |
| G0379 | Direct admission of patient for hospital observation care | 66 | 63 | $25K |
| 85730 | 21,247 | 20,464 | $25K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | 239 | 232 | $25K |
| 74019 | 3,880 | 3,726 | $25K | |
| 96368 | 1,778 | 1,129 | $25K | |
| G0008 | Administration of influenza virus vaccine | 1,398 | 1,385 | $24K |
| 82378 | 2,370 | 1,933 | $23K | |
| 87641 | 955 | 943 | $23K | |
| 20680 | 14 | 14 | $23K | |
| 73630 | 3,849 | 3,722 | $23K | |
| 84112 | 517 | 495 | $23K | |
| 83970 | 563 | 524 | $23K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 1,276 | 1,216 | $23K |
| 95816 | 85 | 84 | $23K | |
| 85240 | 1,272 | 1,171 | $23K | |
| Q5103 | Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg | 14 | 12 | $23K |
| 73130 | 3,027 | 2,946 | $23K | |
| 81329 | 453 | 450 | $22K | |
| 73610 | 3,947 | 3,824 | $22K | |
| H2025 | Ongoing support to maintain employment, per 15 minutes | 80 | 75 | $22K |
| 36592 | 1,972 | 1,535 | $22K | |
| 85651 | 5,101 | 4,964 | $22K | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 1,712 | 1,491 | $21K |
| J9000 | Injection, doxorubicin hydrochloride, 10 mg | 916 | 561 | $21K |
| 82962 | 32,148 | 29,305 | $21K | |
| 86880 | 1,175 | 1,025 | $21K | |
| H1005 | Prenatal care, at-risk enhanced service package (includes h1001-h1004) | 576 | 427 | $21K |
| J2270 | Injection, morphine sulfate, up to 10 mg | 8,534 | 7,636 | $21K |
| 97802 | 1,164 | 1,122 | $20K | |
| 92585 | 155 | 153 | $20K | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 7,416 | 5,466 | $20K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 15,804 | 12,911 | $20K |
| T1013 | Sign language or oral interpretive services, per 15 minutes | 1,583 | 1,549 | $19K |
| J9395 | Injection, fulvestrant, 25 mg | 46 | 36 | $19K |
| 81513 | 359 | 356 | $19K | |
| C9290 | Injection, bupivacaine liposome, 1 mg | 68 | 68 | $19K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 1,380 | 1,361 | $19K |
| Q0222 | Injection, bebtelovimab, 175 mg | 12 | 12 | $19K |
| 84484 | 24,747 | 23,227 | $19K | |
| S2900 | Surgical techniques requiring use of robotic surgical system (list separately in addition to code for primary procedure) | 370 | 363 | $18K |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 53 | 52 | $18K |
| 86762 | 2,202 | 2,175 | $18K | |
| 92004 | Ophthalmological services: medical examination and evaluation, comprehensive, new patient | 124 | 118 | $18K |
| 90734 | 809 | 807 | $18K | |
| 85384 | 3,601 | 3,298 | $18K | |
| 73562 | 2,772 | 2,708 | $18K | |
| 73030 | 2,820 | 2,724 | $18K | |
| 90744 | 2,858 | 2,856 | $17K | |
| 80074 | 794 | 781 | $17K | |
| 86765 | 2,365 | 2,337 | $17K | |
| 99441 | 426 | 408 | $17K | |
| 99443 | 385 | 213 | $17K | |
| 73110 | 2,537 | 2,460 | $17K | |
| 42830 | 13 | 13 | $17K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 6,469 | 5,984 | $17K |
| 92504 | 219 | 206 | $17K | |
| 83690 | 29,669 | 28,252 | $16K | |
| 99442 | 260 | 231 | $16K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | 680 | 680 | $16K |
| J9201 | Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 422 | 215 | $16K |
| 96377 | 1,077 | 797 | $15K | |
| 87340 | 4,925 | 4,869 | $15K | |
| 84550 | 5,969 | 5,290 | $15K | |
| 90700 | 2,119 | 2,113 | $15K | |
| 88184 | 214 | 214 | $15K | |
| 73090 | 3,084 | 2,788 | $15K | |
| A9541 | Technetium tc-99m sulfur colloid, diagnostic, per study dose, up to 20 millicuries | 67 | 66 | $15K |
| 85246 | 874 | 822 | $15K | |
| J7300 | Intrauterine copper contraceptive (paragard) | 14 | 14 | $15K |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg | 996 | 569 | $15K |
| J1170 | Injection, hydromorphone, up to 4 mg | 4,308 | 3,509 | $15K |
| J1642 | Injection, heparin sodium, (heparin lock flush), per 10 units | 9,498 | 5,797 | $15K |
| 84439 | 4,234 | 4,097 | $15K | |
| 83605 | 15,873 | 14,844 | $14K | |
| 82746 | 2,147 | 2,080 | $14K | |
| 87481 | 358 | 355 | $14K | |
| 31579 | 65 | 65 | $13K | |
| 73590 | 2,542 | 2,394 | $13K | |
| 90685 | 1,050 | 1,045 | $13K | |
| 81267 | 132 | 79 | $13K | |
| 82105 | 2,007 | 1,917 | $13K | |
| 86870 | 500 | 475 | $13K | |
| 90648 | 1,616 | 1,613 | $12K | |
| 72158 | 37 | 37 | $12K | |
| 99383 | 115 | 102 | $12K | |
| 95782 | 13 | 13 | $12K | |
| 87631 | 344 | 340 | $12K | |
| J7307 | Etonogestrel (contraceptive) implant system, including implant and supplies | 30 | 30 | $12K |
| 86300 | 994 | 915 | $12K | |
| 94760 | 3,026 | 2,865 | $12K | |
| 72157 | 27 | 27 | $11K | |
| 73564 | 1,434 | 1,401 | $11K | |
| 86787 | 2,252 | 2,223 | $11K | |
| 84156 | 4,504 | 3,939 | $11K | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 8,519 | 7,901 | $11K |
| 87040 | 10,048 | 9,675 | $11K | |
| 73080 | 2,190 | 2,113 | $11K | |
| 84238 | 264 | 243 | $11K | |
| J0690 | Injection, cefazolin sodium, 500 mg | 4,906 | 4,772 | $11K |
| 72100 | 1,038 | 1,023 | $11K | |
| 73221 | 29 | 28 | $10K | |
| 90677 | 61 | 61 | $10K | |
| 74220 | 193 | 192 | $10K | |
| J3475 | Injection, magnesium sulfate, per 500 mg | 3,229 | 2,342 | $10K |
| J3489 | Injection, zoledronic acid, 1 mg | 78 | 75 | $10K |
| 85018 | 11,008 | 10,112 | $10K | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 6,610 | 6,291 | $10K |
| 88360 | 204 | 198 | $10K | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 10,841 | 10,359 | $9K |
| J3480 | Injection, potassium chloride, per 2 meq | 1,855 | 1,296 | $9K |
| 86304 | 810 | 711 | $9K | |
| 29130 | 43 | 43 | $9K | |
| 86140 | 7,207 | 6,962 | $9K | |
| J1644 | Injection, heparin sodium, per 1000 units | 2,304 | 1,831 | $9K |
| 80076 | 890 | 871 | $9K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | 507 | 501 | $9K |
| 81243 | 175 | 174 | $8K | |
| 86334 | 574 | 551 | $8K | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 8,951 | 6,647 | $8K |
| 76978 | 26 | 26 | $8K | |
| 84146 | 671 | 666 | $8K | |
| 88112 | 233 | 225 | $8K | |
| 73502 | 1,046 | 1,021 | $7K | |
| 97533 | 89 | 24 | $7K | |
| D0140 | Limited oral evaluation - problem focused | 73 | 60 | $7K |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | 34 | 33 | $7K |
| 87522 | Neg quan hep c or qual rna | 199 | 197 | $7K |
| G0475 | Hiv antigen/antibody, combination assay, screening | 614 | 608 | $7K |
| 83521 | 483 | 459 | $7K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | 77 | 76 | $7K |
| 90656 | 1,008 | 1,004 | $7K | |
| 73140 | 1,186 | 1,164 | $7K | |
| 93308 | 27 | 27 | $7K | |
| 88237 | 85 | 84 | $7K | |
| 89051 | 350 | 306 | $7K | |
| J9260 | Injection, methotrexate sodium, 50 mg | 1,941 | 1,309 | $6K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 380 | 308 | $6K |
| 93880 | 12 | 12 | $6K | |
| 86335 | 167 | 163 | $6K | |
| 90472 | Immunization administration, each additional vaccine (list separately) | 700 | 692 | $6K |
| J9171 | Injection, docetaxel, 1 mg | 31 | 25 | $6K |
| L8699 | Prosthetic implant, not otherwise specified | 65 | 63 | $6K |
| 99386 | 41 | 41 | $6K | |
| 73060 | 1,228 | 1,193 | $6K | |
| 86706 | 971 | 960 | $6K | |
| 92604 | 105 | 99 | $6K | |
| 85732 | 839 | 804 | $6K | |
| J2997 | Injection, alteplase recombinant, 1 mg | 26 | 24 | $6K |
| 87186 | 5,781 | 5,646 | $5K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 399 | 399 | $5K |
| 84480 | 1,639 | 1,572 | $5K | |
| 85379 | 4,478 | 4,400 | $5K | |
| 82677 | 445 | 432 | $5K | |
| D2930 | Prefabricated stainless steel crown - primary tooth | 12 | 12 | $5K |
| 74240 | 65 | 64 | $5K | |
| D1120 | Prophylaxis - child | 135 | 111 | $5K |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 689 | 555 | $5K |
| 90620 | 82 | 82 | $5K | |
| 73552 | 861 | 833 | $5K | |
| 82570 | 4,072 | 3,824 | $5K | |
| 87799 | 124 | 108 | $5K | |
| 87081 | 5,992 | 5,944 | $5K | |
| 82668 | 388 | 385 | $5K | |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 41 | 40 | $5K |
| 57454 | 12 | 12 | $4K | |
| 90785 | 49 | 28 | $4K | |
| 62270 | 30 | 30 | $4K | |
| J9060 | Injection, cisplatin, powder or solution, 10 mg | 187 | 80 | $4K |
| 72170 | 909 | 893 | $4K | |
| J2060 | Injection, lorazepam, 2 mg | 3,017 | 2,627 | $4K |
| 86905 | 149 | 126 | $4K | |
| 82950 | 1,505 | 1,494 | $4K | |
| 82043 | 832 | 815 | $4K | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 1,051 | 1,019 | $4K |
| 86320 | 130 | 127 | $4K | |
| 88271 | 87 | 84 | $4K | |
| 82951 | 364 | 362 | $4K | |
| 83010 | 644 | 558 | $4K | |
| 87077 | 3,330 | 3,256 | $4K | |
| J0171 | Injection, adrenalin, epinephrine, 0.1 mg | 506 | 443 | $4K |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 1,168 | 1,117 | $4K |
| 89050 | 1,484 | 1,258 | $4K | |
| J0561 | Injection, penicillin g benzathine, 100,000 units | 27 | 27 | $4K |
| 97537 | 41 | 14 | $4K | |
| 92523 | 12 | 12 | $4K | |
| 99417 | Prolong home eval add 15m | 157 | 153 | $4K |
| 76937 | 24 | 24 | $4K | |
| 80178 | 675 | 611 | $4K | |
| 73620 | 682 | 658 | $3K | |
| 83001 | 301 | 299 | $3K | |
| 86301 | 360 | 301 | $3K | |
| 86704 | 601 | 593 | $3K | |
| 82150 | 1,445 | 1,312 | $3K | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 1,495 | 1,159 | $3K |
| 86336 | 776 | 729 | $3K | |
| 87529 | 114 | 111 | $3K | |
| 86481 | 74 | 74 | $3K | |
| 88275 | 70 | 70 | $3K | |
| 77001 | 12 | 12 | $3K | |
| 86665 | 785 | 775 | $3K | |
| D0274 | Bitewings - four radiographic images | 53 | 13 | $3K |
| 87070 | 2,401 | 2,338 | $3K | |
| D1206 | Topical application of fluoride varnish | 116 | 116 | $3K |
| 0042T | 51 | 50 | $3K | |
| 87640 | 924 | 907 | $3K | |
| 73070 | 833 | 799 | $3K | |
| 82330 | 1,212 | 1,156 | $3K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 15 | 14 | $3K |
| Q3014 | Telehealth originating site facility fee | 290 | 173 | $3K |
| S9484 | Crisis intervention mental health services, per hour | 12 | 12 | $3K |
| 87205 | 2,539 | 2,458 | $3K | |
| 84132 | 12,668 | 11,772 | $3K | |
| 82565 | 4,302 | 4,021 | $3K | |
| 17250 | 12 | 12 | $3K | |
| 86147 | 96 | 96 | $2K | |
| C9113 | Injection, pantoprazole sodium, per vial | 719 | 689 | $2K |
| 88173 | 85 | 82 | $2K | |
| J0736 | Injection, clindamycin phosphate, 300 mg | 341 | 301 | $2K |
| Q0114 | Fern test | 491 | 464 | $2K |
| 82947 | 12,479 | 11,658 | $2K | |
| C2617 | Stent, non-coronary, temporary, without delivery system | 44 | 42 | $2K |
| 76506 | 38 | 38 | $2K | |
| J9075 | Injection, cyclophosphamide, not otherwise specified, 5 mg | 18 | 12 | $2K |
| J1650 | Injection, enoxaparin sodium, 10 mg | 537 | 465 | $2K |
| 87536 | 41 | 41 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 853 | 843 | $2K |
| 82232 | 195 | 190 | $2K | |
| 80197 | 187 | 75 | $2K | |
| 80047 | 131 | 110 | $2K | |
| T1006 | Alcohol and/or substance abuse services, family/couple counseling | 15 | 12 | $2K |
| 84436 | 1,802 | 1,770 | $2K | |
| 90732 | 140 | 132 | $2K | |
| 95819 | 12 | 12 | $2K | |
| 85611 | 295 | 285 | $2K | |
| 81002 | 3,188 | 3,051 | $2K | |
| 87497 | 60 | 52 | $2K | |
| 86663 | 658 | 650 | $2K | |
| 84145 | 898 | 878 | $2K | |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 530 | 525 | $2K |
| 82550 | 4,469 | 4,345 | $2K | |
| 87521 | Neg quan hep c or qual rna | 70 | 69 | $2K |
| Q0091 | Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory | 1,143 | 1,125 | $2K |
| 70544 | 28 | 26 | $2K | |
| J0461 | Injection, atropine sulfate, 0.01 mg | 402 | 239 | $2K |
| 73120 | 109 | 105 | $2K | |
| J1630 | Injection, haloperidol, up to 5 mg | 2,037 | 1,809 | $2K |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 1,613 | 1,604 | $2K |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 861 | 857 | $2K |
| 69200 | 13 | 13 | $2K | |
| 84295 | 12,020 | 11,181 | $1K | |
| 86664 | 655 | 647 | $1K | |
| 84165 | 291 | 284 | $1K | |
| 90713 | 240 | 239 | $1K | |
| 99241 | 13 | 12 | $1K | |
| Q9963 | High osmolar contrast material, 350-399 mg/ml iodine concentration, per ml | 217 | 215 | $1K |
| 96127 | 837 | 833 | $1K | |
| 84704 | 194 | 184 | $1K | |
| 85044 | 422 | 421 | $1K | |
| 85014 | 7,986 | 7,393 | $1K | |
| 85652 | 767 | 759 | $1K | |
| 88300 | 143 | 139 | $1K | |
| 76813 | 14 | 14 | $1K | |
| 86160 | 203 | 191 | $1K | |
| 85670 | 215 | 212 | $1K | |
| 82435 | 11,600 | 10,786 | $1K | |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | 12 | 12 | $1K |
| 83986 | 519 | 489 | $1K | |
| J1596 | Injection, glycopyrrolate, 0.1 mg | 345 | 345 | $1K |
| 58301 | 13 | 12 | $1K | |
| 87486 | 95 | 95 | $1K | |
| 87581 | 95 | 95 | $1K | |
| 76010 | 154 | 139 | $1K | |
| 88311 | 107 | 107 | $1K | |
| 76800 | 12 | 12 | $993.02 | |
| 82652 | 45 | 44 | $972.29 | |
| 62272 | 41 | 38 | $833.68 | |
| 88331 | 117 | 116 | $830.14 | |
| 87150 | 29 | 29 | $824.79 | |
| 80164 | 305 | 291 | $820.13 | |
| 80159 | 62 | 52 | $801.01 | |
| J2543 | Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) | 221 | 210 | $787.97 |
| 90649 | 15 | 15 | $763.57 | |
| G0009 | Administration of pneumococcal vaccine | 50 | 49 | $761.81 |
| 88367 | 12 | 12 | $758.31 | |
| 85250 | 26 | 25 | $748.20 | |
| 82247 | 993 | 923 | $731.37 | |
| 73560 | 85 | 83 | $700.57 | |
| 82272 | 814 | 770 | $684.39 | |
| 82553 | 1,201 | 1,174 | $662.63 | |
| H1000 | Prenatal care, at-risk assessment | 15 | 13 | $633.12 |
| 86146 | 59 | 57 | $607.87 | |
| 86038 | 128 | 126 | $602.78 | |
| 87400 | 495 | 493 | $601.64 | |
| 87625 | 234 | 233 | $588.70 | |
| 86430 | 127 | 127 | $584.58 | |
| J1953 | Injection, levetiracetam, 10 mg | 57 | 54 | $582.50 |
| J2371 | Injection, phenylephrine hydrochloride, 20 micrograms | 787 | 760 | $582.40 |
| 92134 | 16 | 15 | $562.32 | |
| 82010 | 929 | 860 | $541.42 | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 14 | 12 | $535.62 |
| 73100 | 100 | 97 | $533.89 | |
| J0610 | Injection, calcium gluconate (fresenius kabi), per 10 ml | 42 | 36 | $489.88 |
| 73592 | 13 | 12 | $474.50 | |
| 88302 | 54 | 54 | $471.31 | |
| J0612 | Injection, calcium gluconate, not otherwise specified, 10 mg | 30 | 24 | $435.76 |
| 84155 | 290 | 283 | $429.88 | |
| S0028 | Injection, famotidine, 20 mg | 483 | 302 | $426.37 |
| 77417 | 75 | 40 | $417.21 | |
| 80069 | 40 | 38 | $415.57 | |
| J1940 | Injection, furosemide, up to 20 mg | 369 | 302 | $395.76 |
| J7042 | 5% dextrose/normal saline (500 ml = 1 unit) | 117 | 115 | $395.69 |
| 86360 | 12 | 12 | $395.60 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 208 | 206 | $394.80 |
| 99354 | 30 | 30 | $391.66 | |
| C1758 | Catheter, ureteral | 14 | 13 | $389.43 |
| 82310 | 327 | 301 | $386.78 | |
| 73600 | 125 | 122 | $386.07 | |
| 86225 | 101 | 100 | $385.07 | |
| 85613 | 41 | 41 | $361.47 | |
| 82977 | 92 | 76 | $355.38 | |
| 83002 | 12 | 12 | $330.12 | |
| 86039 | 141 | 136 | $313.24 | |
| 84481 | 60 | 60 | $297.00 | |
| 84466 | 65 | 65 | $279.79 | |
| 86593 | 100 | 99 | $269.41 | |
| 85013 | 2,799 | 2,618 | $255.60 | |
| 70360 | 132 | 131 | $252.42 | |
| 86359 | 12 | 12 | $249.56 | |
| C7901 | Service for diagnosis, evaluation, or treatment of a mental health or substance use disorder, 30-60 minutes, provided remotely by hospital staff who are licensed to provided mental health services under applicable state law(s), when the patient is in their home, and there is no associated professional service | 26 | 12 | $248.56 |
| 88313 | 16 | 16 | $237.12 | |
| 83520 | 15 | 13 | $236.78 | |
| 99355 | 29 | 29 | $223.63 | |
| 85335 | 29 | 26 | $208.90 | |
| 73000 | 41 | 40 | $204.88 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 83 | 76 | $204.33 |
| 87075 | 227 | 220 | $203.76 | |
| 82438 | 41 | 41 | $199.15 | |
| 82525 | 14 | 14 | $192.89 | |
| 82952 | 81 | 81 | $185.04 | |
| 98960 | 13 | 12 | $181.84 | |
| 90662 | 19 | 19 | $176.29 | |
| 83921 | 12 | 12 | $176.13 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 18 | 12 | $175.68 |
| 73660 | 47 | 45 | $170.61 | |
| 86644 | 12 | 12 | $124.57 | |
| 71101 | 80 | 80 | $112.98 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 41 | 32 | $108.87 |
| J2470 | Injection, pantoprazole sodium, 40 mg | 50 | 49 | $105.31 |
| 72040 | 12 | 12 | $101.69 | |
| J3370 | Injection, vancomycin hcl, 500 mg | 41 | 39 | $97.62 |
| 86778 | 12 | 12 | $95.39 | |
| 82180 | 12 | 12 | $84.04 | |
| 82009 | 720 | 710 | $79.66 | |
| 90657 | 34 | 34 | $76.65 | |
| J2004 | Injection, lidocaine hcl with epinephrine, 1 mg | 97 | 97 | $74.93 |
| J2795 | Injection, ropivacaine hydrochloride, 1 mg | 30 | 30 | $71.55 |
| J0456 | Injection, azithromycin, 500 mg | 33 | 31 | $70.29 |
| 84703 | 1,901 | 1,836 | $65.91 | |
| J1836 | Injection, metronidazole, 10 mg | 52 | 50 | $53.80 |
| J7070 | Infusion, d5w, 1000 cc | 102 | 86 | $45.80 |
| 80177 | 37 | 37 | $38.07 | |
| 83721 | 53 | 52 | $30.50 | |
| 82948 | 38 | 38 | $28.00 | |
| 84478 | 14 | 13 | $26.87 | |
| J0744 | Injection, ciprofloxacin for intravenous infusion, 200 mg | 12 | 12 | $24.91 |
| 87116 | 17 | 16 | $21.60 | |
| 86308 | 483 | 478 | $20.08 | |
| 87102 | 15 | 14 | $16.82 | |
| 87206 | 13 | 13 | $16.17 | |
| 99152 | 13 | 12 | $13.37 | |
| 87015 | 12 | 12 | $9.84 | |
| J3411 | Injection, thiamine hcl, 100 mg | 13 | 13 | $4.51 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 21 | 21 | $4.00 |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 212 | 202 | $0.00 |
| 99429 | 33 | 28 | $0.00 | |
| 99080 | 7,400 | 2,048 | $0.00 | |
| 81257 | 13 | 13 | $0.00 | |
| 86618 | 13 | 13 | $0.00 | |
| 82365 | 13 | 12 | $0.00 | |
| 73020 | 42 | 42 | $0.00 | |
| 70250 | 13 | 12 | $0.00 | |
| 88365 | 13 | 13 | $0.00 |